+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-09Number of Pages: 161

Clostridium Vaccine (Animal Health) Market (Animal Species - Bovine, Ovine, Caprine, Swine, and Poultry; Distribution Channel - Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute, and Retail Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Clostridium Vaccines Market: Snapshot

Clostridium vaccines are chiefly utilized for a variety of bovine and ovine clostridial diseases such as blackleg, pulpy kidney (enterotoxaemia), black disease, and tetanus. The demand for clostridium vaccine is rising globally owing to the increasing incidence rate of clostridium family diseases and increased awareness regarding zoonotic diseases. Rising concerns about the mortality of livestock animal and the socioeconomic impact of it on agrarian economies are also increasing the demand for clostridium vaccines in developing countries globally.

Clostridium vaccine is are chiefly distributed through veterinary clinics and veterinary hospitals. In developing countries such as India, the distribution of these vaccines is highly dependent on government intervention. However, there has been a significant rise in the demand for these vaccines through retail pharmacies, which allow instant access to these vaccines without having to wait for government channels to distribute them.

The global clostridium vaccine (animal health) market is poised to observe significant growth in the future. Transparency Market Research estimates that the market was valued at US$418.0 mn in 2015 and is expected to reach US$643.5 mn by 2024, expanding at a CAGR of 4.9% from 2016 to 2024.

clostridium vaccine market

Bovine Segment to Bring in Significant Percentage of Sales

On the basis of animal species, the global clostridium vaccine market is segmented into bovine, ovine, caprine, swine, and poultry. Of these, the swine segment emerged as the most attractive segment of the market in 2015. The large share of the segment in the global market's overall revenues can be attributed to the large demand of pork and high awareness about the possibility of swines causing zoonotic diseases.

Over the forecast period, however, the ovine segment is likely to record the most promising growth rate. The rising prevalence of diseases such as blackleg, black diseases, and black quarter, along with the vast rise in the world's ovine population, growing awareness among owners, and government regulations in different geographies will be key to the increased demand for clostridium vaccines across this segment. In addition, the increase in demand for immunization has led to the growth of this segment. Poultry is also expected grow with high growth rate due to increase consumption of poultry goods.

Rising Awareness Regarding Animal Health to Boost Demand across Asia Pacific

Geographically, North America was the leading market for the clostridium vaccine market in 2015. The region accounted for a share of 37.6% of the market and is expected to continue to constitute the bulk of the global market’s revenue over the forecast period as well. Rising demand for effective veterinary healthcare services and substantial government interventions for research and development are the key factors supporting the North America market’s growth.

The swine segment in North America accounted for the dominant share of 25.3% share in 2015. A wide range of applications, including clostridium perfringens and clostridium botulinum are likely to support the growth of the segment in the next few years.

Nevertheless, the clostridium vaccine market in Asia Pacific is anticipated to outpace the rate of growth of the North America market over the forecast period owing to a vast rise in prevalence of clostridium disease infections in developing countries such as India and China. India and New Zealand are expected to be more lucrative than other countries in Asia Pacific due to increased awareness as well as increasing livestock animal population in these countries. Veterinary clinic as distribution channel holds the dominant market share due to increasing government awareness regarding the diseases across several countries in the region.

The global clostridium vaccine (animal health) market features a largely consolidated competitive landscape, with a relatively small number of companies accounting for a majority of share in the global market. Some of the key players in the market Zoetis, Inc., Merck Animal Health, Sanofi-Aventis (Merial Animal Health), BoehringerIngelheim, Eli Lilly and Company (Elanco Animal Healthcare), Vibrac Corporation, Bimeda, Inc., CevaSanteAnimale, and Bayer AG.

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section-2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Clostridium Vaccine (Animal Health) Market: Market Snapshot
3.2 Global Clostridium Vaccine (Animal Health) Market: Opportunity Map

Section-4 Market Overview
4.1 Global Clostridium Vaccine (Animal Health) Market: Product Overview
4.2 Global Clostridium Vaccine (Animal Health) Market: Key Industry Developments
4.3 Regulatory Scenario

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
      5.1.2 Drivers
              5.1.2.1 Growing incidence of clostridium family 
              5.1.2.2 Increase in disposable income
              5.1.2.3 Increase in interventions by government bodies
              5.1.2.4 Rise in demand for cattle milk, meat and eggs
              5.1.2.5 Spending on livestock animals to grow globally
              5.1.2.6 Population growth and improved standard of living
              5.1.2.7 Growing awareness among people
              5.1.2.8 Increase in R&D expense as key strategy
      5.1.3 Restraints
              5.1.3.1 High treatment Cost
              5.1.3.2 High dependence on government distribution channel
              5.1.3.3 Stringent Regulations
      5.1.4 Opportunity
              5.1.4.1 Technological Development and Innovation
              5.1.4.2 Significant Scope in Emerging Markets
5.2 Opportunity Analysis
5.3 Key Trends
5.4 Global Clostridium Vaccine (Animal Health) Market Revenue and Volume Projection
5.5 Porter’s Five Forces Analysis
5.6 Clostridium Vaccine (Animal Health) Market Outlook

Section-6 Clostridium Vaccine (Animal Health) Market Analysis, by Animal Species
6.1 Key Findings
6.2 Introduction
6.3 Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
6.4 Clostridium Vaccine (Animal Health) Market Forecast, by Animal Species
      6.4.1 Bovine
      6.4.2 Ovine
      6.4.3 Caprine
      6.4.4 Swine
      6.4.5 Poultry
      6.4.6 Others
6.5 Clostridium Vaccine (Animal Health) Market Attractiveness Analysis

Section-7 Clostridium Vaccine (Animal Health) Market Analysis, by Distribution Channel
7.1 Key Findings
7.2 Introduction
7.3 Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
7.4 Clostridium Vaccine (Animal Health) Market Forecast, by Distribution Channel
      7.4.1 Veterinary Clinic
      7.4.2 Veterinary Hospital
      7.4.3 Veterinary Research Institute
      7.4.4 Retail Pharmacy
7.5 Clostridium Vaccine (Animal Health) Market Attractiveness Analysis

Section-8 Clostridium Vaccine (Animal Health) Market Analysis, by Region
8.1 Geographical Scenario
8.2 Introduction
8.3 Clostridium Vaccine (Animal Health) Market Value Share Analysis
8.4 Clostridium Vaccine (Animal Health) Market Forecast
8.5 Clostridium Vaccine (Animal Health) Market Attractiveness Analysis

Section-9 North America Clostridium Vaccine (Animal Health) Market Analysis
9.1 North America Clostridium Vaccine (Animal Health) Market Overview
9.2 North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
9.3 North America Clostridium Vaccine (Animal Health) Market Forecast
9.4 North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
9.5 North America Clostridium Vaccine (Animal Health) Market Forecast
9.6 North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
9.7 North America Clostridium Vaccine (Animal Health) Market Forecast, by Country
9.8 North America Market Attractiveness Analysis

Section-10 Europe Clostridium Vaccine (Animal Health) Market Analysis
10.1 Europe Clostridium Vaccine (Animal Health) Market Overview
10.2 Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
10.3 Europe Clostridium Vaccine (Animal Health) Market Forecast
10.4 Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
10.5 Europe Clostridium Vaccine (Animal Health) Market Forecast
10.6 Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
10.7 Europe Clostridium Vaccine (Animal Health) Market Forecast, by Country
10.8 Europe Market Attractiveness Analysis

Section-11 Asia Pacific Clostridium Vaccine (Animal Health) Market Analysis
11.1 Asia Pacific Clostridium Vaccine (Animal Health) Market Overview
11.2 Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
11.3 Asia Pacific Clostridium Vaccine (Animal Health) Market Forecast
11.4 Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
11.5 Asia Pacific Clostridium Vaccine (Animal Health) Market Forecast
11.6 Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
11.7 Asia Pacific Clostridium Vaccine (Animal Health) Market Forecast, by Country
11.8 Asia Pacific Market Attractiveness Analysis

Section-12 Latin America Clostridium Vaccine (Animal Health) Market Analysis
12.1 Latin America Clostridium Vaccine (Animal Health) Market Overview
12.2 Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
12.3 Latin America Clostridium Vaccine (Animal Health) Market Forecast
12.4 Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
12.5 Latin America Clostridium Vaccine (Animal Health) Market Forecast
12.6 Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
12.7 Latin America Clostridium Vaccine (Animal Health) Market Forecast, by Country
12.8 Latin America Market Attractiveness Analysis

Section-13 Middle East & Africa Clostridium Vaccine (Animal Health) Market Analysis
13.1 Middle East & Africa Clostridium Vaccine (Animal Health) Market Overview
13.2 Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
13.3 Middle East & Africa Clostridium Vaccine (Animal Health) Market Forecast
13.4 Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
13.5 Middle East & Africa Clostridium Vaccine (Animal Health) Market Forecast
13.6 Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
13.7 Middle East & Africa Clostridium Vaccine (Animal Health) Market Forecast, by Country
13.8 Middle East & Africa Market Attractiveness Analysis

Section-14 Competition Landscape 
14.1 Clostridium Vaccine (Animal Health) Market Share Analysis By Company (2015)
14.2 Competition Matrix
14.3 Company Profiles
      14.3.1 Bayer AG 
              14.3.1.1. Company Overview
              14.3.1.2. Business Overview
              14.3.1.3. Financial Overview
              14.3.1.4. SWOT Analysis
              14.3.1.5. Strategic Overview
      14.3.2 Bimeda, Inc. 
              14.3.2.1. Company Overview
              14.3.2.2. Business Overview
              14.3.2.3. Financial Overview
              14.3.2.4. SWOT Analysis
              14.3.2.5. Strategic Overview
      14.3.3 Boehringer Ingelheim GmbH 
              14.3.3.1. Company Overview
              14.3.3.2. Business Overview
              14.3.3.3. Financial Overview
              14.3.3.4. SWOT Analysis
              14.3.3.5. Strategic Overview
      14.3.4 Ceva Sante Animale 
              14.3.4.1. Company Overview
              14.3.4.2. Business Overview
              14.3.4.3. Financial Overview
              14.3.4.4. SWOT Analysis
              14.3.4.5. Strategic Overview
      14.3.5 Eli Lilly and Company (Elanco Animal Health) 
              14.3.5.1. Company Overview
              14.3.5.2. Business Overview
              14.3.5.3. Financial Overview
              14.3.5.4. SWOT Analysis
              14.3.5.5. Strategic Overview
      14.3.6 Merck Animal Health 
              14.3.6.1. Company Overview
              14.3.6.2. Business Overview
              14.3.6.3. Financial Overview
              14.3.6.4. SWOT Analysis
              14.3.6.5. Strategic Overview
      14.3.7 Sanofi S.A. (Merial Animal Health) 
              14.3.7.1. Company Overview
              14.3.7.2. Business Overview
              14.3.7.3. Financial Overview
              14.3.7.4. SWOT Analysis
              14.3.7.5. Strategic Overview
      14.3.8 Virbac
              14.3.8.1. Company Overview
              14.3.8.2. Business Overview
              14.3.8.3. Financial Overview
              14.3.8.4. SWOT Analysis
              14.3.8.5. Strategic Overview
      14.3.9 Zoetis, Inc.
              14.3.9.1. Company Overview
              14.3.9.2. Business Overview
              14.3.9.3. Financial Overview
              14.3.9.4. SWOT Analysis
              14.3.9.5. Strategic Overview

List of Figures

Figure 1: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Type, 2016 and 2024
Figure 3: Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Animal Species
Figure 4: Global Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 5: Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Distribution Channel
Figure 6: Global Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Region, 2016 and 2024
Figure 7: Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Region
Figure 8: North America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 9: North America Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 10: North America Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 11: North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 12: North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 13: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 14: North America Market Attractiveness Analysis, by Animal Species 
Figure 15: North America Market Attractiveness Analysis, by Distribution Channel
Figure 16: Europe Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 17: Europe Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 18: Europe Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 19: Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species, 2016 & 2024
Figure 20: Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 21: Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country, 2016 and 2024
Figure 22: Europe Market Attractiveness Analysis, by Animal Species 
Figure 23: Europe Market Attractiveness Analysis, by Distribution Channel
Figure 24: Asia Pacific Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 25: Asia Pacific Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 26: Asia Pacific Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 27: Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 28: Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 29: Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country, 2016 & 2024
Figure 30: Asia Pacific Market Attractiveness Analysis, by Animal Species 
Figure 31: Asia Pacific Market Attractiveness Analysis, by Distribution Channel
Figure 32: Latin America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 33: Latin America Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 34: Latin America Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 35: Latin America Clostridium vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 36: Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 37: Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country, 2016 & 2024
Figure 38: Latin America Market Attractiveness Analysis, by Animal Species 
Figure 39: Latin America Market Attractiveness Analysis, by Distribution Channel
Figure 40: Middle East & Africa Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 41: Middle East & Africa Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 42: Middle East & Africa Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 43: Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 44: Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 45: Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
Figure 46: Middle East & Africa Market Attractiveness Analysis, by Animal Species 
Figure 47: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
Figure 48: Global Clostridium Vaccine (Animal Health) Market Share Analysis By Company (2015)

List of Tables

Table 1: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species, 2014–2024
Table 2: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Distribution Channel
Table 3: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 4: North America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species
Table 5: North America Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 6: North America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 7: Europe Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species, 2014–2024
Table 8: Europe Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 9: Europe Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 10: Asia Pacific Clostridium Vaccine (Animal) Market Size (US$ Mn) Forecast, by Animal Species, 2014–2024
Table 11: Asia Pacific Clostridium Vaccine (Animal health) Forecast, by Distribution Channel, 2014–2024
Table 12: Asia Pacific Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Latin America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species,
Table 14: Latin America Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 15: Latin America Clostridium Vaccine Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 16: Middle East & Africa Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species
Table 17: Middle East & Africa Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 18: Middle East & Africa Clostridium Vaccine Market Size (US$ Mn) Forecast, by Country, 2014–2024

Global Clostridium Vaccine (Animal Health) Market: Scope of the Report

This report on the clostridium vaccine (animal health) market studies the current as well as future prospects of the market globally. Health concern related to life threatening diseases are the major concerns in the developed and developing nations.

This research report provides a detailed analysis of the clostridium vaccine (animal health) market and helps understand the various driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the market. Porter’s five forces analysis has been covered in terms of bargaining power of buyers and suppliers, threat of new entrants and substitutes, and competitive rivalry in the global clostridium vaccine (animal health) market. Market dynamics factors such as market attractiveness analysis have also been explained in order to deliver a thorough analysis of the overall competitive scenario of the global clostridium vaccine (animal health) market.

Global Clostridium Vaccine (Animal Health) Market: Segmentation

The clostridium vaccine (animal health) market has been segmented by animal species, by distribution channel and by region. The animal species segment has been sub-segmented into bovine, ovine, caprine, swine, poultry and others. The distribution channel segment has been sub-segments into veterinary clinic, veterinary hospital, veterinary research institute and retail pharmacy.

The executive summary provides detailed insights about the report and the market in general. This elaborate executive summary provides a glimpse into the present scenario of the global clostridium vaccine (animal health) market, which includes a market snapshot that provides overall information of various segments and sub-segments. The executive summary also provides overall information and data analysis of the global clostridium vaccine (animal health) market with respect to market segments based on animal species, distribution channel as well as geographic regions. The market for clostridium vaccine (animal health) has been extensively analyzed based on their usefulness, effectiveness, sales revenue and geographic presence. The market size and forecast in terms of US$ Mn for each animal species and distribution channel has been provided for the period from 2016 to 2024. This report on the clostridium vaccine (animal health) market also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Clostridium Vaccine (Animal Health) Market: Geographical and Competitive Dynamics

Geographically, the clostridium vaccine (animal health) market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2024, along with CAGR (%) for the forecast period from 2016 to 2024. The research study also incorporates the competitive scenario in these regions.

A list of recommendations has been provided for new entrants as well as existing players to help establish a strong presence in the market and increase market share. The report also profiles major players in the clostridium vaccine (animal health) market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Zoetis, Inc., Merck Animal Health, Sanofi-Aventis (Merial Animal Health), Boehringer Ingelheim, Eli Lilly and Company (Elanco Animal Healthcare), Vibrac Corporation, Bimeda, Inc., Ceva Sante Animale and Bayer AG.

The global clostridium vaccine (animal health) market is segmented as follows:

  • Global Clostridium Vaccine (Animal Health) Market Revenue, by Animal Species
    • Bovine
    • Ovine
    • Caprine
    • Swine
    • Poultry
    • Others
       
  • Global Clostridium Vaccine (Animal Health) Market Revenue, by Distribution Channel
    • Veterinary Clinic
    • Veterinary Hospital
    • Veterinary Research institute
    • Retail Pharmacy
       
  • Global Clostridium Vaccine (Animal Health) Market Revenue, by Geography
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Australia
      • New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East and Africa
      • Saudi Arabia
      • South Africa
      • Rest of Middle East & Africa


 
 
Back To Top